NWK Group’s Idexx Laboratories IDXX Stock Holding History

NWK Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-24	Closed	-$8K	–	217
2020 Q2	$8K	Buy	+24	New	+$6.95K	﹤0.01%	190

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

NWK Group's IDXX Position: Q3 2020 in Review

NWK Group sold out of Idexx Laboratories (IDXX) in Q3 2020, closing a stake of 24 shares — an estimated $8K sold.

NWK Group first reported a position in IDXX in Q2 2020 and held it in 1 quarter. The position peaked at $8K in Q2 2020. 846 funds tracked by Wall St. Rank hold IDXX as of Q3 2020.

NWK Group reported no remaining Idexx Laboratories position as of Q3 2020 after selling out during the quarter.
NWK Group sold 24 Idexx Laboratories shares in Q3 2020, an estimated $8K.
NWK Group first reported a position in Idexx Laboratories in Q2 2020 and held it in 1 quarter.
NWK Group's Idexx Laboratories position peaked at $8K in Q2 2020.
846 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2020.

Based on NWK Group's 13F filing for Q3 2020, filed 16 Nov 2020.